Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
Leukemic stem cells which are resistant to chemotherapy are proposed as relapse-initiating cells (RICs). Here, the authors show that targeting the adrenomedullin-calcitonin receptor-like receptor decreases RICs frequency improving chemotherapy response in AML preclinical models.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e5db0cc7b23d4c7f80b655c467b00921 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e5db0cc7b23d4c7f80b655c467b00921 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e5db0cc7b23d4c7f80b655c467b009212021-12-02T13:48:51ZAdrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells10.1038/s41467-020-20717-92041-1723https://doaj.org/article/e5db0cc7b23d4c7f80b655c467b009212021-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-20717-9https://doaj.org/toc/2041-1723Leukemic stem cells which are resistant to chemotherapy are proposed as relapse-initiating cells (RICs). Here, the authors show that targeting the adrenomedullin-calcitonin receptor-like receptor decreases RICs frequency improving chemotherapy response in AML preclinical models.Clément LarrueNathan GuiraudPierre-Luc MouchelMarine DuboisThomas FargeMathilde GotanègreClaudie BoscEstelle SalandMarie-Laure Nicolau-TraversMarie SabatierNizar SerhanAmbrine SahalEmeline BoetSarah MoucheQuentin HeydtNesrine ArouaLucille StuaniTony KaomaLinus AngenendtJan-Henrik MikeschChristoph SchliemannFrançois VergezJérôme TamburiniChristian RécherJean-Emmanuel SarryNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Clément Larrue Nathan Guiraud Pierre-Luc Mouchel Marine Dubois Thomas Farge Mathilde Gotanègre Claudie Bosc Estelle Saland Marie-Laure Nicolau-Travers Marie Sabatier Nizar Serhan Ambrine Sahal Emeline Boet Sarah Mouche Quentin Heydt Nesrine Aroua Lucille Stuani Tony Kaoma Linus Angenendt Jan-Henrik Mikesch Christoph Schliemann François Vergez Jérôme Tamburini Christian Récher Jean-Emmanuel Sarry Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells |
description |
Leukemic stem cells which are resistant to chemotherapy are proposed as relapse-initiating cells (RICs). Here, the authors show that targeting the adrenomedullin-calcitonin receptor-like receptor decreases RICs frequency improving chemotherapy response in AML preclinical models. |
format |
article |
author |
Clément Larrue Nathan Guiraud Pierre-Luc Mouchel Marine Dubois Thomas Farge Mathilde Gotanègre Claudie Bosc Estelle Saland Marie-Laure Nicolau-Travers Marie Sabatier Nizar Serhan Ambrine Sahal Emeline Boet Sarah Mouche Quentin Heydt Nesrine Aroua Lucille Stuani Tony Kaoma Linus Angenendt Jan-Henrik Mikesch Christoph Schliemann François Vergez Jérôme Tamburini Christian Récher Jean-Emmanuel Sarry |
author_facet |
Clément Larrue Nathan Guiraud Pierre-Luc Mouchel Marine Dubois Thomas Farge Mathilde Gotanègre Claudie Bosc Estelle Saland Marie-Laure Nicolau-Travers Marie Sabatier Nizar Serhan Ambrine Sahal Emeline Boet Sarah Mouche Quentin Heydt Nesrine Aroua Lucille Stuani Tony Kaoma Linus Angenendt Jan-Henrik Mikesch Christoph Schliemann François Vergez Jérôme Tamburini Christian Récher Jean-Emmanuel Sarry |
author_sort |
Clément Larrue |
title |
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells |
title_short |
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells |
title_full |
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells |
title_fullStr |
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells |
title_full_unstemmed |
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells |
title_sort |
adrenomedullin-calcrl axis controls relapse-initiating drug tolerant acute myeloid leukemia cells |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/e5db0cc7b23d4c7f80b655c467b00921 |
work_keys_str_mv |
AT clementlarrue adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT nathanguiraud adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT pierrelucmouchel adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT marinedubois adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT thomasfarge adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT mathildegotanegre adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT claudiebosc adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT estellesaland adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT marielaurenicolautravers adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT mariesabatier adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT nizarserhan adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT ambrinesahal adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT emelineboet adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT sarahmouche adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT quentinheydt adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT nesrinearoua adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT lucillestuani adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT tonykaoma adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT linusangenendt adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT janhenrikmikesch adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT christophschliemann adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT francoisvergez adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT jerometamburini adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT christianrecher adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells AT jeanemmanuelsarry adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells |
_version_ |
1718392471652663296 |